Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract

The Journal of Clinical Investigation
A M CantinR G Crystal


We hypothesized that the alveolar structures may contain extracellular macromolecules with antioxidant properties to defend against oxidants. To evaluate this 51Cr-labeled human lung fibroblasts (HFL-1) and cat lung epithelial cells (AKD) were exposed to a H2O2-generating system and alveolar epithelial lining fluid (ELF) from healthy nonsmokers was tested for its ability to protect the lung cells from H2O2-mediated injury. The ELF provided marked antioxidant protection, with most from a H2O-soluble fraction in the 100-300-kD range. Plasma proteins with anti-H2O2 properties were in insufficient concentrations to provide the antioxidant protection observed. However, catalase, a normal intracellular antioxidant, was present in sufficient concentration to account for most of the observed anti-H2O2 properties of ELF. Depletion of ELF with an anticatalase antibody abolished the anti-H2O2 macromolecular defenses of ELF. Since catalase is not normally released by cells, a likely explanation for its presence in high concentrations in normal ELF is that it is released by lung inflammatory and parenchymal cells onto the epithelial surface of the lower respiratory tract during their normal turnover and collects there due to the slow turnov...Continue Reading


Aug 1, 1978·The Journal of Experimental Medicine·J Schnyder, M Baggiolini
Mar 30, 1978·The New England Journal of Medicine·B M Babior
Jul 1, 1978·Annals of Internal Medicine·J M McCord, I Fridovich
Sep 8, 1978·Science·I Fridovich
Feb 7, 1978·Biochemistry·G E Hook
Jan 1, 1975·Annual Review of Biochemistry·I Fridovich
Jun 1, 1971·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P Petrik
Nov 1, 1971·Analytical Biochemistry·W WoodburyM A Stahman
Dec 1, 1972·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A B NovikoffN Quintana
Mar 1, 1972·The Journal of Clinical Investigation·T P StosselM Vaughan
Jun 1, 1972·Archives of Biochemistry and Biophysics·J BonaventuraS Fang
Jan 1, 1983·Lung·L SkozaY Kikkawa
Jan 1, 1980·Annual Review of Biochemistry·J A Badwey, M L Karnovsky
Sep 1, 1980·Annals of Internal Medicine·S J Klebanoff
Sep 1, 1983·The Journal of Clinical Investigation·P A WardC Beauchamp
Apr 1, 1981·The Journal of Clinical Investigation·K J JohnsonP A Ward
Feb 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·W F PetroneJ M McCord

❮ Previous
Next ❯


Sep 25, 2004·Medicinal Research Reviews·Stuti SrivastavaDinesh K Dikshit
Sep 22, 1993·Molecular and Cellular Biochemistry·U Chatterjee, G G Sanwal
Jan 1, 1991·Lung·A M Cantin, R Bégin
Nov 1, 1995·Free Radical Biology & Medicine·E M PostlethwaitA Bidani
Jan 1, 1996·Free Radical Biology & Medicine·I Rahman, W MacNee
Aug 11, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·B ZappacostaP De Sole
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P A Sandstrom, T M Buttke
Jan 1, 1996·Critical Care Medicine·M ContrerasJ J Zimmerman
Sep 1, 1995·Archives of Disease in Childhood. Fetal and Neonatal Edition·C H Fardy, M Silverman
Sep 12, 2012·Oxidative Medicine and Cellular Longevity·O F Araneda, M Tuesta
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·F J SaldíasJ I Sznajder
Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·M KawashimaH Wada
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·V VallyathanV Castranova
Apr 3, 2001·American Journal of Respiratory and Critical Care Medicine·M CorradiP J Barnes
Aug 1, 1993·The American Review of Respiratory Disease·D B PedenM A Kaliner
Jul 14, 2010·American Journal of Respiratory and Critical Care Medicine·Neal S GouldBrian J Day
May 23, 2002·American Journal of Respiratory and Critical Care Medicine·Benjamin Gaston, John F Hunt
May 16, 2003·American Journal of Respiratory Cell and Molecular Biology·Julie A WickendenWilliam MacNee
Apr 19, 2003·American Journal of Respiratory Cell and Molecular Biology·Neil R HackettRonald G Crystal
Jan 1, 1993·The Journal of Clinical Investigation·A Cantin, D E Woods
Sep 18, 2001·Biological & Pharmaceutical Bulletin·K IsuzugawaY Ogihara
Apr 13, 2002·Japanese Journal of Pharmacology·Stefan MátyásViktor Bauer
Dec 1, 1994·Environmental Health Perspectives·C E CrossB Halliwell
Dec 1, 1994·Environmental Health Perspectives·D T WrightK B Adler
Oct 28, 1998·Environmental Health Perspectives·C E CrossB Halliwell
Nov 4, 2005·Proceedings of the American Thoracic Society·William MacNee
May 1, 1992·Experimental Lung Research·L A Cohn, K B Adler
Jan 1, 1997·Experimental Lung Research·S Y GardnerJ I Everitt
Jun 10, 2000·Chest·W MacNee
Oct 19, 2010·Biochemical Pharmacology·Neal S Gould, Brian J Day
Aug 28, 2007·Clinics in Chest Medicine·William Macnee
Oct 16, 2009·Pediatric Pulmonology·Carlo DaniFirmino F Rubaltelli
May 7, 2010·Clinical and Translational Science·Wei Lee, Paul S Thomas

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.